Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra in Inflammatory Pustular Dermatoses
NCT01794117Phase 2Completed
- Sponsor
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Start
- Jul 2013
- Primary completion
- Mar 2019
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of anakinra in pustular psoriasis, subcorneal pustular dermatosis (SPD), acrodermatitis continua of Hallopeau (ACH), palmoplantar pustulosis (PPP), reactive arthritis, sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases. Started Jul 2013; status: completed.
02
Drugs
anakinra
03
Conditions
pustular psoriasissubcorneal pustular dermatosis (SPD)acrodermatitis continua of Hallopeau (ACH)palmoplantar pustulosis (PPP)reactive arthritis
Beyond the preview
Go deeper on NCT01794117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01794117.